Mirum Pharmaceuticals, Inc.
MIRM
Ранг среди акций
#3243
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Цена акции
$83.62
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$5.43B
Изменение (1 день)
-1.71%
Изменение (1 год)
20.14%
Страна
US
Торговля Mirum Pharmaceuticals, Inc. (MIRM)
Категория
Healthcare
История цены акций Mirum Pharmaceuticals, Inc. (MIRM)
Наивысшая цена закрытия: $82.31 2026-10-01
Наименьшая цена закрытия: $13.66 2019-07-01
Наименьшая цена закрытия: $13.66 2019-07-01
История цены акций Mirum Pharmaceuticals, Inc. с 2019 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | 28.91% |
| 2025 | 68.24% |
| 2024 | 35.06% |
| 2023 | 73.09% |
| 2022 | 24.19% |
| 2021 | -29.47% |
| 2020 | 29.71% |
| 2019 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
